Spire Wealth Management Horizon Therapeutics Public LTD CO Transaction History

Spire Wealth Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$98.98 - $115.74 $1,088 - $1,273	-11 Reduced 16.92%	54 $6,000
Q2 2023 Aug 09, 2023	BUY	$96.34 - $112.38 $1,059 - $1,236	11 Added 20.37%	65 $6,000
Q1 2023 May 09, 2023	BUY	$107.32 - $113.5 $3,648 - $3,859	34 Added 170.0%	54 $5,000
Q3 2022 Nov 07, 2022	SELL	$58.92 - $84.67 $471 - $677	-8 Reduced 28.57%	20 $1,000
Q2 2022 Jul 22, 2022	SELL	$79.4 - $116.36 $2,858 - $4,188	-36 Reduced 56.25%	28 $2,000

Q1 2022 Apr 18, 2022	SELL	$86.42 - $109.81 $1,296 - $1,647	-15 Reduced 18.99%	64 $7,000
Q4 2021 Jan 14, 2022	BUY	$98.56 - $119.91 $1,478 - $1,798	15 Added 23.44%	79 $9,000
Q3 2021 Oct 22, 2021	BUY	$91.91 - $110.37 $3,308 - $3,973	36 Added 128.57%	64 $7,000
Q2 2021 Jul 26, 2021	SELL	$86.24 - $95.92 $1,207 - $1,342	-14 Reduced 33.33%	28 $3,000
Q1 2021 May 21, 2021	BUY	$71.83 - $95.48 $3,016 - $4,010	42 New	42 $4,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.